Cargando…
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Autor principal: | Kim, Dong Uk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018296/ https://www.ncbi.nlm.nih.gov/pubmed/36918270 http://dx.doi.org/10.5009/gnl210585.e |
Ejemplares similares
-
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2022) -
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy [Corrigendum]
Publicado: (2019) -
Corrigendum: treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy
Publicado: (2023) -
Corrigendum to: Antemortem diagnosis of nonbacterial thrombotic endocarditis in a patient with previously resected pancreatic adenocarcinoma: a case report
Publicado: (2020) -
[Corrigendum] Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer
por: Gassler, Nikolaus, et al.
Publicado: (2023)